
    
      Primary objective: identify geriatric biomarkers associated with vital/functional status
      after TAVR.

      Primary outcome measure is altered functional status at six month follow-up defined as an
      absolute decrease of 15 points of the Barthel Index.

      Secondary outcome measures are: Barthel index and survival at 6, 9 and 12 months follow-up.
      QOL during follow-up
    
  